Gemseki logo

Gemseki

Asia, Tokyo, Japan, Akasaka

Description

Gemseki is a portal platform company supporting the development of drug candidates.

Investor Profile

Gemseki has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Series Unknown (33%)

Country Focus

  • Japan (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Analytics
  • Nursing And Residential Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gemseki frequently co-invest with?

Future Venture Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
Creative Ventures
North America, California, United States, Oakland
Co-Investments: 1
Prox Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Asahi Kasei Pharma
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Wilson Sonsini Goodrich & Rosati
North America, California, United States, Palo Alto
Co-Investments: 1
Kyoto University Innovation Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KreaMedica
North America, Quebec, Canada, Montréal
Co-Investments: 1
Kyushin Social Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1

Which angels does Gemseki often collaborate with?

JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Gemseki?

Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series ANov 3, 2023
Amount Raised: $11,703,095
Toregem BioPharma

Kyoto, Kyoto, Japan

Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownMar 8, 2022
Amount Raised: $3,888,495
Curreio

Shinjuku, Yamanashi, Japan

Curreio is a biotechnology platform that provides contract business for structural analysis using cryo-electron microscopy.

AnalyticsBiotechnologyMedicalNursing and Residential Care
Series AJun 23, 2021